Health Care Deal News: Spotlight on Biotechnology- May 2012
In April’s largest Biotechnology deal, the British-Swedish pharmaceutical company AstraZeneca plc (NYSE: AZN) is acquiring Ardea Biosciences (NASDAQ: RDEA), a biotech that is focused on the discovery and development of small-molecule therapeutics treating gout and...The Dealmakers Forum E-Newsletter- May 23, 2012
Bringing You Senior Care M&A Deals and News May 23, 2012 Issue: Seniors Housing Weekly Update: 60 Seconds with Steve Monroe Recent Senior Care M&A Deals Expert Opinion: A Conversation with Imran Javaid Conference Calendar Seniors Housing Weekly Update:...Health Care Deal News: Spotlight on Biotechnology- April 2012
In March’s largest biotech deal, the Belgian firm ThromboGenics NV (Euronext: THR) is entering into an agreement with Novartis AG (NYSE: NVS) for the commercialization of ocriplasmin outside of the United States. This product candidate is indicated for the treatment...Health Care Deal News- May 21, 2012
Brought to you by www.DealSearchOnline.com May 21, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Long-Term Care Spotlight on: Venture Capital Conference Calendar Recent Health Care M&A Deals BIOTECHNOLOGY Acquirer Target Price...The SeniorCare Investor: The Auction At The Clare At Water Tower A Success
Senior Care Development Wins Bid For Premier CCRC All eyes were on Chicago during the second week of April, as two bids were received for The Clare at Water Tower to compete with the $29.5 million stalking horse bid from an affiliate of Senior Care Development (SCD)...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
